In 2019, C2CRx member companies spent 47% PMPM less than the Industry National Average; Since drugs represent 20 to 30% of a plans costs, this represents 10 to 12%
Care2Care secured a strategic partnership with an innovative, transparent, 100% pass-through PBM. Adding to our expertise in international drug sourcing, we expand our offer to the full pharmacy benefit management.
Our PBM solution in short.
We offer a transparent, 100% Pass Through solution. Our model is a “Cost +” model,
Meaning Cost of the drug + a moderate admin fee. Our drug formulary design is founded in science, thanks to a partnership with an independent academic system. This eliminates conflict of interest, in particular for Specialty drugs guidance.
